Waldemar Debinski
35Patents
11h-index
21Co-inventors
75Inventor score
Filing activity: Mar 4, 1991 → Nov 16, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5614191A | IL-13 receptor specific chimeric proteins and uses thereof | Chemistry; Metallurgy | 67 | Expired |
| US5328984A | Recombinant chimeric proteins deliverable across cellular membranes into cytosol of target cells | Chemistry; Metallurgy | 55 | Expired |
| US6428788B1 | Compositions and methods for specifically targeting tumors | Chemistry; Metallurgy | 47 | Expired |
| US6518061B1 | IL-13 receptor specific chimeric proteins and uses thereof | Chemistry; Metallurgy | 46 | Expired |
| US5919456A | IL-13 receptor specific chimeric proteins | Chemistry; Metallurgy | 44 | Expired |
| US6576232B1 | IL13 mutants | Chemistry; Metallurgy | 33 | Expired |
| US7338929B2 | Cancer immunotherapy | Human Necessities | 29 | Expired |
| US6296843A | Mutagenized IL 13-based chimeric molecules | Chemistry; Metallurgy | 24 | Expired |
| US8362207B2 | Multi-level specific targeting of cancer cells with IL-13 | Physics | 17 | Active |
| US6630576B2 | Amino acid substitution mutants of interleukin 13 | Chemistry; Metallurgy | 17 | Expired |
| US6884603B2 | Nucleic acids encoding IL13 mutants | Chemistry; Metallurgy | 14 | Expired |
| US9005600B2 | Compounds useful for multi-level specific targeting of cancer cells | Physics | 4 | Active |
| US7598058B2 | Nucleic acids encoding IL13 mutants | Chemistry; Metallurgy | 4 | Expired |
| US7960361B2 | Nucleic acid cancer immunotherapy | Human Necessities | 3 | Active |
| US8435534B2 | Cancer immunotherapy | Human Necessities | 3 | Active |
| US9771404B2 | Multi-level specific targeting of cancer cells | Physics | 2 | Active |
| US6884581B2 | Method for identifying a test compound that modulates expression of a Fra-1 gene in a brain cancer cell | Chemistry; Metallurgy | 2 | Expired |
| US8343461B2 | Molecular signature of cancer | Chemistry; Metallurgy | 2 | Active |
| US10233224B2 | Nucleic acids encoding a fusion protein useful for multi-level specific targeting of cancer cells | Physics | 1 | Active |
| US11207380B2 | Molecular signature of cancer | Chemistry; Metallurgy | 1 | Active |
| US10752667B2 | EPHA3 and multi-valent targeting of tumors | Chemistry; Metallurgy | 1 | Active |
| US11976101B2 | Multi-level specific targeting of cancer cells | Physics | 0 | Active |
| US9975942B2 | EPHA3 And multi-valent targeting of tumors | Chemistry; Metallurgy | 0 | Active |
| US12419934B2 | Molecular signature of cancer | Chemistry; Metallurgy | 0 | Active |
| US9290558B2 | Molecular signature of cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.